Number of SLNs | Location of SLNs | Time (h) | Tilmanocept injected (nmol) | Percentage injected dose* | IRDye800CW (nmol) | Extraction (%)* | Fluorescence intensity (kcts s−1 μW−1)† |
8 | Popliteal | 1.0 | 1.7 | 0.95 ± 0.78 | 0.024 ± 0.020‡ | 99.4 ± 4.0 | 6.22 ± 2.45‡ |
8 | Popliteal | 36.0 | 1.7 | 0.56 ± 0.39‡ | 0.014 ± 0.010‡ | 98.5 ± 0.9 | 8.62 ± 3.72‡ |
8 | Popliteal | 1.0 | 8.4 | 1.64 ± 0.77 | 0.21 ± 0.10 | 95.1 ± 5.2 | 19.1 ± 9.23 |
8 | Popliteal | 36.0 | 8.4 | 1.21 ± 0.33 | 0.15 ± 0.04 | 94.2 ± 5.9 | 11.6 ± 4.24 |